RxDoctor Payments Data

Tamara Batson

Family · Nashville, TNNPI 1740352970

Payments from drug & device makers

$1,087in general payments, 2019–2025

Across 78 payments — averaging $13.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$246
  • Lilly USA, LLC$143
  • Boehringer Ingelheim$137
  • AbbVie$118
  • Johnson & Johnson$77
  • Abbott$64
  • plus $302 from 12 others

What the payments were for

  • Food & beverage$1,086100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,087 in reported general payments places this provider in the 65th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$55,492
Medicare patients
180
Services billed
879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin76$86,073
MounjaroTirzepatide67$68,233
RybelsusSemaglutide17$35,064
XareltoRivaroxaban26$31,098
OzempicSemaglutide23$27,776
EliquisApixaban16$15,042
Breo ElliptaFluticasone/Vilanterol16$6,847
Duloxetine Hcl78$1,965
Rosuvastatin Calcium123$1,491
Pantoprazole Sodium86$1,339
Atorvastatin Calcium125$1,268
Famotidine66$1,116
Losartan Potassium91$1,092
Levothyroxine Sodium132$1,070
Gabapentin43$1,040

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$137$86,07376 claims
Lilly USA, LLCMounjaro$143$68,23367 claims
Novo NordiskRybelsus, Ozempic$246$62,84040 claims
Johnson & JohnsonXarelto$77$31,09826 claims
PfizerEliquis$45$15,04216 claims
GSKBreo Ellipta$43$6,84716 claims
AbbVieSynthroid$118$55612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,706 family providers in Tennessee.

Other family in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →